Treatment Advances
Brigham and Women's Mesothelioma Program Is Expanding Access to Combination Immunotherapy for Patients Who Were Once Out of Options
Yvette Abrego2 days ago
FDA approvals, new therapies, clinical trial results, and emerging mesothelioma treatments.